Acetazolamide

Product NDC
64380-834
11-digit product format
643800834
Labeler code
64380
Product ID
64380-834_69be4b8b-13c5-48f6-8c8b-58b7879152c0
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Acetazolamide
Dosage form
TABLET
Route
ORAL
Labeler
Strides Pharma Science Limited
Application
ANDA209734
Marketing category
ANDA
Marketing start
2017-11-20
Substance
ACETAZOLAMIDE
Active strength
250 mg/1
Pharmacologic classes
Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage64380-83464380-834-46DDiscontinued by firm2026-08-07

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A209734-001ACETAZOLAMIDEACETAZOLAMIDE125MGTABLET / ORALAB2017-11-20
A209734-002ACETAZOLAMIDEACETAZOLAMIDE250MGTABLET / ORALAB2017-11-20

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A209734-001AB
A209734-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-20011fe1cb6892…
2026-02-19 14:30 UTC2026-02A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-20011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-2031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-2031067a03dcf5…
2025-08-23 18:47 UTC2025-08A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-206a471c1ec25d…
2025-08-23 18:47 UTC2025-08A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-206a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-20fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-20fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-20b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-20b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-2003ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-2003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-202680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-202680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-205bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-205bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-20d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-20d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-20d06236e962d9…
2024-10-29 15:01 UTC2024-10A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-20d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-2079d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-2079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-20301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-20301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-201e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-201e350fbaab3a…
2024-05-31 18:47 UTC2024-05A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-208072bd15b7f6…
2024-05-31 18:47 UTC2024-05A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-208072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-205c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-205c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-205d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-205d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-204b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-204b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-2074a2ff9319b5…
2019-12-13 00:20 UTC2019-12A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-2074a2ff9319b5…
2022-03-09 01:35 UTC2022-03A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-20bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-20bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A209734-001ACETAZOLAMIDE125MGTABLET / ORALAB2017-11-20782e0a99824c…
2021-12-28 21:50 UTC2021-12A209734-002ACETAZOLAMIDE250MGTABLET / ORALAB2017-11-20782e0a99824c…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A209734-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A209734-002AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A209734-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A209734-002AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A209734-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A209734-002AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A209734-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A209734-002AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A209734-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A209734-002AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A209734-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A209734-002AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A209734-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A209734-002AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A209734-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A209734-002AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A209734-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A209734-002AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A209734-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A209734-002AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A209734-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A209734-002AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A209734-001AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A209734-002AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A209734-001AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A209734-002AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A209734-001AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05A209734-002AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A209734-001AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A209734-002AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A209734-001AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A209734-002AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A209734-001AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A209734-002AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A209734-001AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A209734-002AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A209734-001AB1bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A209734-002AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A209734-001AB1782e0a99824c…
2021-12-28 21:50 UTC2021-12A209734-002AB1782e0a99824c…

Additional Listing Data#

Finished product
Yes
Brand name base
Acetazolamide
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ACETAZOLAMIDE250 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
O3FX965V0IInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
197303Internal RxNorm lookup
197304Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
4813b9dd-5f58-44bb-ad64-cdb331828080Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
94b5d997-68ee-d92e-7c04-a34fdb427a66Product name920240509
d0adda24-c2d3-39f8-a845-ede9cd56b2c4Product name620210513
91efc97d-7785-4097-b6cf-4201369f41ebProduct name320190711

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
64380-834-06Acetazolamide100 in 1 BOTTLETABLET10010
64380-834-46Acetazolamide1000 in 1 BAGTABLET100010

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
64380-834-06EA - Each64380-834eae42124-5285-4c5d-80e9-2fdef9a03bf712017-12-14

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
64380-834ACETAZOLAMIDE TABLET [STRIDES PHARMA SCIENCE LIMITED]7Current NDC, Legacy NDC, 2 package rows20250129_4813b9dd-5f58-44bb-ad64-cdb331828080.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AcetazolamideACETAZOLAMIDEPD-Rx Pharmaceuticals, Inc.268db224-d5db-457c-86bc-972c9fe079172026-07-07Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209734
application number: ANDA209734
AcetazolamideACETAZOLAMIDEStrides Pharma Science Limited4813b9dd-5f58-44bb-ad64-cdb3318280802026-07-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209734
application number: ANDA209734
ndc (product): 64380-834
AcetazolamideACETAZOLAMIDEAvPAKa9dca448-5511-413e-e053-2a95a90a8c662026-01-08Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209734
application number: ANDA209734
AcetazolamideACETAZOLAMIDENuCare Pharmaceuticlas, Inc.278878bc-da9c-09d4-e063-6394a90abaf72024-11-22Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209734
application number: ANDA209734
AcetazolamideACETAZOLAMIDEA-S Medication Solutionse9152bc5-5817-4a6a-9d2a-0dd77074f5012024-06-05Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209734
application number: ANDA209734
AcetazolamideACETAZOLAMIDEProficient Rx LP3cdde6aa-c89d-4ea4-aade-6c8b5c3ffdcc2019-10-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209734
application number: ANDA209734

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
197303acetaZOLAMIDE 125 MG Oral TabletPSN4813b9dd-5f58-44bb-ad64-cdb33182808010
197304acetaZOLAMIDE 250 MG Oral TabletPSN4813b9dd-5f58-44bb-ad64-cdb33182808010
197303acetazolamide 125 MG Oral TabletSCD4813b9dd-5f58-44bb-ad64-cdb33182808010
197304acetazolamide 250 MG Oral TabletSCD4813b9dd-5f58-44bb-ad64-cdb33182808010
197304acetaZOLAMIDE 250 MG Oral TabletPSNe9152bc5-5817-4a6a-9d2a-0dd77074f5015
197304acetazolamide 250 MG Oral TabletSCDe9152bc5-5817-4a6a-9d2a-0dd77074f5015
197304acetaZOLAMIDE 250 MG Oral TabletPSNa9dca448-5511-413e-e053-2a95a90a8c664
197304acetazolamide 250 MG Oral TabletSCDa9dca448-5511-413e-e053-2a95a90a8c664

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
64380-834-0664380083406100 TABLET in 1 BOTTLE (64380-834-06) 100 tablet2017-11-200000-00-00NoNoCurrent
64380-834-46643800834461000 TABLET in 1 BAG (64380-834-46) 1000 tablet2017-11-200000-00-00NoNoCurrent